Our analysis revealed that the expression of DDX11—a gene not known to be associated with ccRCC—was upregulated in aggressive ccRCC compared to that in non-aggressive ccRCC, and that this upregulation was significantly related to poor overall survival (p < 0.05) [9]. This evidence concerns the gene DDX11 and nonpapillary renal cell carcinoma.